Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa is a major pathogen in cystic fibrosis (CF) lung disease. Children with CF are routinely exposed to P. aeruginosa from the natural environment, and by adulthood, 80% of patients are chronically infected.P. aeruginosa in the CF airway exhibits a unique biofilm-like structure, where it grows in small clusters or aggregates of bacteria in association with abundant polymers of neutrophil-derived components F-actin and DNA, among other components. These aggregates differ substantially in size and appearance compared to surface-attached in vitro biofilm models classically utilized for studies but are believed to share properties of surface-attached biofilms, including antibiotic resistance. However, little is known about the formation and function of surface-independent modes of biofilm growth, how they might be eradicated, and quorum sensing communication. To address these issues, we developed a novel in vitro model of P. aeruginosa aggregates incorporating human neutrophil-derived products. Aggregates grown in vitro and those found in CF patients' sputum samples were morphologically similar; viable bacteria were distributed in small pockets throughout the aggregate. The lasA quorum sensing gene was differentially expressed in the presence of neutrophil products. Importantly, aggregates formed in the presence of neutrophils acquired resistance to tobramycin, which was lost when the aggregates were dispersed with DNase, and antagonism of tobramycin and azithromycin was observed. This novel yet simple in vitro system advances our ability to model infection of the CF airway and will be an important tool to study virulence and test alternative eradication strategies against P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The acquired antibiotic resistance was lost upon DNAse treatment and the consequent disintegration of the aggregates, showing a direct correlation between autoaggregation and antimicrobial resistance [114].”
From Bacterial autoaggregation (2018) · cites this paper as [114]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Aggregation has also been shown to influence pathogenesis by increasing tolerance against antimicrobial agents [3],[11],[114], elevating invasion frequency as well as invasion efficiency of host cells [42], impeding phagocytosis by cells of the host immune system [14], or increasing survival within phagosomes [13].”
From Bacterial autoaggregation (2018) · cites this paper as [114]
The cited source says what the claim attributes to it.
In the citing paper
“The formation of aggregates by P. aeruginosa is enhanced by human neutrophils [114],[131] and an early-stage neutrophil-induced aggregation confers antibiotic resistance and selective upregulation of quorum sensing signaling resulting in an enhanced virulence.”
From Bacterial autoaggregation (2018) · cites this paper as [114]
The cited source says what the claim attributes to it.
In the citing paper
“The formation of aggregates by P. aeruginosa is enhanced by human neutrophils [114],[131] and an early-stage neutrophil-induced aggregation confers antibiotic resistance and selective upregulation of quorum sensing signaling resulting in an enhanced virulence.”
From Bacterial autoaggregation (2018) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537 · cited 1×
“The static 96-well format can be used to test for biofilm growth by staining the biomass with crystal violet or for viability with LIVE/DEAD staining (47, 48).”
MethodCeri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155 · cited 1×
“The static 96-well format can be used to test for biofilm growth by staining the biomass with crystal violet or for viability with LIVE/DEAD staining (47, 48).”
MethodPseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691 · cited 3×
“spectively, and sequentially expressed in early biofilm formation (34);”
BackgroundQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519 · cited 6×
“aeruginosa and contains dead and dying neutrophils (6, 26).”
BackgroundResultInfluentialEstablishment of infection: lessons from a versatile opportunist
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01259-4 · Cited by 1,341
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Self-citationEarly pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263 · cited 1×
“From the time of early childhood, cystic fibrosis (CF) lung disease features increased inflammation and persistent neutrophil accumulation in the airways, independent of detectable infection (1).”
BackgroundA genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190 · cited 1×
“Antibiotic resistance is a clinically important feature evoked by biofilm formation (8, 41, 42).”
Background
Research works printed but not linked: 3
- Cystic Fibrosis Foundation. 2013. Cystic Fibrosis Foundation patient registry. 2012 annual data report to the center directors. Cystic Fibrosis Foundation, Bethesda, MD.
- HaslettCGuthrieLAKopaniakMJohnstonRBJrHensonPM. 1985. Modulation of multiple neutrophil functions by trace amounts of bacterial LPS and by preparative methods. Am. J. Pathol. 119:101–110.
- Cystic Fibrosis Therapeutics Development Network Coordinating Center. 2013. Sputum processing for cytology and inflammatory markers: SOP 508. Cystic Fibrosis Therapeutics Development Network Coordinating Center, Bethesda, MD.
Cited by
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
“into the extracellular polymeric substances (EPSs) of the biofilm itself (282).”
BackgroundTrunk, T., Bacterial Cell Surface Group, S. F. G. A. E. B., S. Khalil, H., & C. Leo, J. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.1.140 · Cited by 444
“Aggregation has also been shown to influence pathogenesis by increasing tolerance against antimicrobial agents [3,11,114], elevating invasion frequency as well as invasion efficiency of host cells [42], impeding phagocytosis by cells of the host immune system [14], or increasing survival within phagosomes [13].”
BackgroundInflammation in cystic fibrosis: An update
Roesch, E. A., Nichols, D. P., & Chmiel, J. F. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.24129 · Cited by 242
Self-citationStaphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance
Beaudoin, T., Yau, Y. C. W., Stapleton, P. J., Gong, Y., Wang, P. W., Guttman, D. S., & Waters, V. (2017) · npj Biofilms and Microbiomes · doi:10.1038/s41522-017-0035-0 · Cited by 158
Evolutionary highways to persistent bacterial infection
Bartell, J. A., Sommer, L. M., Haagensen, J. A. J., Loch, A., Espinosa, R., Molin, S., & Johansen, H. K. (2019) · Nature Communications · doi:10.1038/s41467-019-08504-7 · Cited by 139
Metadata
- Authors
- Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A.
- Affiliations
- National Jewish Health (US)
- Department of Medicine, National Jewish Health, Denver, Colorado, USA
- Harvard University (US)
- Seattle Children's Hospital (US)
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-11
- Volume
- 58
- Issue
- 11
- Pages
- 6851-6860
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC4249413
- OpenAlex
- W2130663948
- Cited by
- 50
- References
- 61
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 14 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 4
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genentech
- National Heart, Lung, and Blood Institute (HL34303, P01HL034303)
- National Institute of Allergy and Infectious Diseases (R01AI110408)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK089507)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- Pseudomonas aeruginosa, cystic fibrosis, bacterial aggregates, antibiotic resistance, tobramycin, azithromycin, quorum sensing, F-actin, DNA, in vitro biofilm model, sputum, DNase, virulence
- MeSH terms
- Anti-Bacterial Agents, Cystic Fibrosis, Humans, Microbial Sensitivity Tests, Neutrophils, Pseudomonas aeruginosa, Pseudomonas Infections, Sputum, Tobramycin, Azithromycin, Biofilms, Drug Resistance, Multiple, Bacterial, Virulence Factors, Metalloproteases, Quorum Sensing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products. https://app.cochat.ai/papers/10.1128/aac.03514-14
- The paper
- Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A. (2014). Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.03514-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.